TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation.
Shi M; Deng W; Bi E; Mao K; Ji Y; Lin G; Wu X; Tao Z; Li Z; Cai X; Sun S; Xiang C; Sun B; Nature Immunology, 2008, vol. 9, issue 4, p 369, ISSN 15292916. ISBN 15292916.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef